ABEO vs PTNQ โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ABEO Captures Institutional Edge (2โ2 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Abeona Therapeutics Inc. Common Stock (ABEO) driven by superior Valuation, Growth & Margin while PTNQ counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, ABEO trades at 18.7x Forward P/E with -186.1% operating margin (+2745.0% YoY revenue) versus PTNQ at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ABEO sits in BREAKDOWN (27th %ile IV; Dealer Gamma Walls on Pro) against PTNQ sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ABEO | PTNQ | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $149.2M | N/A | Larger Scale | ABEO |
| Trailing P/E Ratio Valuation | 18.7x | N/M | Lower Multiple | ABEO |
| Forward P/E Ratio Valuation | 18.7x | N/M | Lower Multiple | ABEO |
| Revenue Growth (YoY) Growth | +2745.0% | N/A | Higher Growth | ABEO |
| Operating Margin (TTM) Profitability | -186.1% | N/A | Higher Margin | ABEO |
| Net Profit Margin Profitability | -160.3% | N/A | Higher Margin | ABEO |
| Return on Equity (ROE) Capital Efficiency | -42.1% | N/A | Higher ROE | ABEO |
| 52-Week Range Position Momentum | 9% ($2โ$8) | 40% ($72โ$92) | Stronger Trend | PTNQ |
| Beta / 30D Volatility Risk Regime | 0.60ฮฒ ยท 149% Vol | 1.40ฮฒ ยท 35% Vol | Lower Realized Risk | PTNQ |
| Unified Institutional Score Composite Signal | 44.9 / 100 (HOLD) | 54.5 / 100 (HOLD) | Higher Composite | PTNQ |